BioSpace News Archive

Drug Development

Idera Pharmaceuticals Presents Positive Translational and Clinical Data Update from Ongoing IMO-2125 Development Program at the 2017 Society for Immunotherapy of Cancer Annual Meeting (SITC)

These data will be presented at 4:45 P.M. E.T. on Saturday, November 11th.

November 9, 2017

·

8 min read

Drug Development

Immuron Successfully Completes NASH Phase II Clinical Study Milestone

The last patient in the Company’s NASH clinical study conducted the final scheduled visit on October 9, following a 28-week study period.

November 9, 2017

·

6 min read

Deals

PharMerica Announces Approval of Merger by Stockholders

The closing of the transaction remains subject to customary closing conditions.

November 9, 2017

·

5 min read

Genetown

Navitor Pharmaceuticals’ Scientific Founder Makes Seminal Discoveries Related to Role of Nutrient Sensors in mTOR Regulation and Activity

Today, Dr. Sabatini published in the journal Science the discovery of a new nutrient sensor in the mTORC1 pathway, SAMTOR

November 9, 2017

·

5 min read

Business

Stericycle, Inc. Announces Partnership With National Safety Council for Opioid Crisis Campaign

NSC has partnered with Stericycle, Inc. to launch a provocative nationwide campaign that will illustrate the faces behind the numbers, educate people on the scope of the problem and promote solutions to address the crisis.

November 9, 2017

·

3 min read

Pharm Country

NY-ESO Data Presented at the Connective Tissue Oncology Society (CTOS) Annual Meeting Confirm Potential of Adaptimmune’s SPEAR T-Cell Therapy

The company released updated data from the ongoing pilot study of NY‑ESO SPEAR T-cells in synovial sarcoma, as well as an overview of study design for the ongoing NY-ESO SPEAR T-cell trial.

November 9, 2017

·

5 min read

Business

Avenue Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

As of September 30, 2017, Avenue’s cash and short-term investments (certificates of deposit) totaled $26.1 million compared to $0.2 million at December 31, 2016, an increase of $25.9 million year-to-date.

November 9, 2017

·

6 min read

Business

Atara Biotherapeutics Announces Third Quarter 2017 Financial Results and Recent Highlights

Cash, cash equivalents and short-term investments as of September 30, 2017 totaled $200.2 million.

November 9, 2017

·

17 min read

Pharm Country

Tobii Pro Launches New Advancement in Eye Trackers for Behavioral Research

In conjunction with the initiation of the Spain clinical site, Abeona has established a local subsidiary to manage clinical trial and regulatory development efforts in Europe.

November 9, 2017

·

2 min read

Business

Sienna Biopharmaceuticals Reports Third Quarter 2017 Financial Results

Total operating expenses for the three months ended Sept. 30, 2017, were approximately $14.3 million.

November 9, 2017

·

1 min read